Esophageal disorders including gastroesophageal reflux disease (GERD), esophagitis, and esophageal ulceration may benefit from BPC-157's demonstrated effects on esophageal sphincter function and mucosal healing in animal models
Specifically, the panel will assess whether those substances should be moved off the Category 2 list a designation reserved for bulk drug substances that present potential safety risks and are therefore ineligible for routine compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act
At our Katy IV drip bar, our experts will work with you to learn your lifestyle needs and medical history
Side Effects Common: mild injection-site pain, headache, nausea, diarrhea Less common: dizziness, anxiety, low potassium This is not a complete list